Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 5.92% vs 0.28% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -25.84% vs 4.82% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -39.03% vs -5.35% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -21.31% vs 37.08% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Sirio Pharma Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 3.25% vs -22.24% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.92% vs 0.28% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 120.80% vs -335.28% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -25.84% vs 4.82% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 142.92% vs -209.04% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -39.03% vs -5.35% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 57.38% vs -54.31% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -21.31% vs 37.08% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






